您的位置: 首页 > 农业专利 > 详情页

ORAL IMMEDIATE RELEASE FORMULATIONS FOR SUBSTITUTED QUINAZOLINONES
专利权人:
RESVERLOGIX CORPORATION
发明人:
SHENOY, NARMADA, R.
申请号:
HK15102378.1
公开号:
HK1201751A
申请日:
2015.03.09
申请国别(地区):
HK
年份:
2015
代理人:
摘要:
The present disclosure relates to novel solid pharmaceutical formulations and process for their preparation. The present disclosure also provides, in part, methods of using the pharmaceutical formulations for regulating the expression of apolipoprotein A-I (ApoA-I), and their use for the treatment and prevention of cardiovascular disease and related disease states, including cholesterol- or lipid-related disorders, such as, for example, atherosclerosis.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充